Kurt J Hilzinger insider trades: Outlook Therapeutics (OTLK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kurt reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | OTLK | ↑ Buy | 400,000 | $0.44 | $177K | Direct | May 27, 2026 (1d) |
| Oct 5, 2022 | OTLK | ↑ Buy | 111,203 | $1.28 | $143K | Direct | Oct 5, 2022 (0d) |
| Oct 3, 2022 | OTLK | ↑ Buy | 88,797 | $1.24 | $111K | Direct | Oct 3, 2022 (0d) |
| Mar 1, 2022 | OTLK | ↑ Buy | 27,708 | $1.69 | $47K | Direct | Mar 3, 2022 (2d) |
| Feb 28, 2022 | OTLK | ↑ Buy | 47,160 | $1.48 | $70K | Direct | Feb 28, 2022 (0d) |
| Feb 23, 2022 | OTLK | ↑ Buy | 175,132 | $1.47 | $257K | Direct | Feb 23, 2022 (0d) |
| Feb 4, 2019 | OTLK | ↑ Buy | 5,983 | $0.80 | $5K | Direct | Feb 6, 2019 (2d) |
| Feb 1, 2019 | OTLK | ↑ Buy | 19,390 | $0.75 | $15K | Direct | Feb 1, 2019 (0d) |
| Jan 29, 2019 | OTLK | ↑ Buy | 32,112 | $0.71 | $23K | Direct | Jan 29, 2019 (0d) |
| Jan 23, 2019 | OTLK | ↑ Buy | 13,015 | $0.68 | $9K | Direct | Jan 24, 2019 (1d) |
| Jan 17, 2019 | OTLK | ↑ Buy | 3,100 | $0.69 | $2K | Direct | Jan 18, 2019 (1d) |
| Jan 15, 2019 | OTLK | ↑ Buy | 6,665 | $0.71 | $5K | Direct | Jan 16, 2019 (1d) |
| Jan 10, 2019 | OTLK | ↑ Buy | 8,845 | $0.71 | $6K | Direct | Jan 11, 2019 (1d) |
| Jan 8, 2019 | OTLK | ↑ Buy | 17,781 | $0.62 | $11K | Direct | Jan 8, 2019 (0d) |
| Jan 3, 2019 | OTLK | ↑ Buy | 17,189 | $0.59 | $10K | Direct | Jan 3, 2019 (0d) |
| Dec 28, 2018 | OTLK | ↑ Buy | 18,354 | $0.53 | $10K | Direct | Dec 28, 2018 (0d) |
| Dec 24, 2018 | OTLK | ↑ Buy | 4,713 | $0.65 | $3K | Direct | Dec 26, 2018 (2d) |
| Jan 29, 2007 | ABC | ↓ Sell | 120,000 | $51.79 | $6.2M | Direct | Jan 30, 2007 (1d) |
| Dec 5, 2005 | ABC | ↓ Sell | 40,000 | $80.00 | $3.2M | Direct | Dec 5, 2005 (0d) |
| Jun 2, 2005 | ABC | ↓ Sell | 38,500 | $65.00 | $2.5M | Direct | Jun 2, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OTLK insiders
Open-market trades in the last 12 months
About Kurt J Hilzinger's insider trades
Kurt J Hilzinger is a director at Outlook Therapeutics (OTLK). Since Jun 2, 2005, Kurt has reported 17 open-market purchases worth $901K and 3 sales worth $11.9M on SEC Form 4. In the last 12 months: 1 buy ($177K).
Their filings also include grants and awards (80 filings), option exercises (5 filings), other transactions (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OTLK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.